Both	O
structure	O
energy	O
and	O
spectra	O
computations	O
indicate	O
that	O
the	O
oxidation	O
functional	O
groups	O
are	O
energetically	O
favorable	O
to	O
aggregate	O
together	O
and	O
to	O
be	O
close	O
to	O
one	O
another	O
on	O
the	O
opposite	O
side	O
of	O
graphene	B-Chemical
surface	O
.	O

The	O
most	O
common	O
drug	O
substrates	O
of	O
these	O
enzymes	O
are	O
ester	B-Chemical
prodrugs	O
specifically	O
designed	O
to	O
enhance	O
oral	O
bioavailability	O
by	O
hydrolysis	O
to	O
the	O
active	O
carboxylic	B-Chemical
acid	I-Chemical
after	O
absorption	O
from	O
the	O
gastrointestinal	O
tract	O
.	O

This	O
study	O
was	O
undertaken	O
to	O
explore	O
if	O
Cd	B-Chemical
-	O
induced	O
oxidative	O
stress	O
down	O
-	O
regulated	O
MSH	O
gene	O
activities	O
.	O

It	O
also	O
attenuated	O
the	O
production	O
of	O
prostaglandin	B-Chemical
E2	I-Chemical
,	O
interleukin	O
-	O
1	O
beta	O
(	O
IL	O
-	O
1	O
beta	O
)	O
,	O
IL	O
-	O
6	O
and	O
tumor	O
necrosis	O
factor	O
alpha	O
by	O
21	O
.	O
2	O
%	O
to	O
86	O
.	O
2	O
%	O
.	O

Fatty	B-Chemical
acids	I-Chemical
present	O
in	O
the	O
high	O
-	O
fat	O
diet	O
induced	O
hyperpermeability	O
of	O
endothelial	O
cells	O
,	O
causing	O
adipocyte	O
differentiation	O
,	O
whereas	O
apelin	O
promoted	O
vascular	O
stabilization	O
.	O

The	O
strain	O
produced	O
a	O
number	O
of	O
secondary	O
metabolites	O
belonging	O
to	O
the	O
chloroazaphilones	B-Chemical
.	O

Using	O
sequential	O
azide	B-Chemical
-	O
alkyne	B-Chemical
chemistry	O
,	O
we	O
also	O
demonstrate	O
multicolor	O
imaging	O
of	O
two	O
different	O
metabolically	O
incorporated	O
unnatural	O
sugars	B-Chemical
.	O

Arylsulfonamide	B-Chemical
inhibitors	O
of	O
aggrecanases	O
as	O
potential	O
therapeutic	O
agents	O
for	O
osteoarthritis	O
:	O
Synthesis	O
and	O
biological	O
evaluation	O
.	O

Consequently	O
,	O
systemic	O
delivery	O
of	O
Ad	O
/	O
chitosan	O
-	O
PEG	B-Chemical
-	I-Chemical
FA	I-Chemical
significantly	O
inhibited	O
the	O
growth	O
of	O
FR	O
-	O
positive	O
tumor	O
,	O
decreasing	O
52	O
.	O
8	O
%	O
compared	O
to	O
the	O
naked	O
Ad	O
-	O
treated	O
group	O
.	O

Inhibitory	O
Effect	O
of	O
Ketoconazole	B-Chemical
on	O
the	O
Pharmacokinetics	O
of	O
a	O
Multireceptor	O
Tyrosine	B-Chemical
Kinase	O
Inhibitor	O
BMS	B-Chemical
-	I-Chemical
690514	I-Chemical
in	O
Healthy	O
Participants	O
:	O
Assessing	O
the	O
Mechanism	O
of	O
the	O
Interaction	O
With	O
Physiologically	O
-	O
Based	O
Pharmacokinetic	O
Simulations	O
.	O

Herein	O
we	O
report	O
novel	O
pyrrole	B-Chemical
-	O
and	O
benzene	B-Chemical
-	O
based	O
hydroxamates	B-Chemical
(	O
8	O
,	O
10	O
)	O
and	O
2	B-Chemical
'	I-Chemical
-	I-Chemical
aminoanilides	I-Chemical
(	O
9	O
,	O
11	O
)	O
bearing	O
the	O
tert	B-Chemical
-	I-Chemical
butylcarbamate	I-Chemical
group	O
at	O
the	O
CAP	O
moiety	O
as	O
histone	O
deacetylase	O
(	O
HDAC	O
)	O
inhibitors	O
.	O

Concentrated	O
BC	O
/	O
PNB	B-Chemical
nanogel	O
dispersion	O
displayed	O
gel	O
a	O
forming	O
capacity	O
in	O
situ	O
by	O
catheter	O
injection	O
,	O
which	O
indicates	O
potential	O
for	O
a	O
wide	O
range	O
of	O
medical	O
applications	O
.	O

Concentrations	O
causing	O
50	O
%	O
inhibition	O
of	O
testosterone	B-Chemical
synthesis	O
for	O
MBP	B-Chemical
and	O
MEHP	B-Chemical
(	O
3	O
and	O
6	O
mu	O
M	O
respectively	O
)	O
,	O
were	O
similar	O
to	O
in	O
vivo	O
values	O
(	O
3	O
and	O
7	O
mu	O
M	O
)	O
.	O

KN	B-Chemical
-	I-Chemical
62	I-Chemical
did	O
not	O
affect	O
D1	O
and	O
D4	O
receptor	O
responses	O
.	O

In	O
addition	O
,	O
increases	O
in	O
hepatic	O
MDA	B-Chemical
and	O
NO	B-Chemical
levels	O
in	O
the	O
BDL	O
-	O
induced	O
cholestasis	O
were	O
attenuated	O
by	O
BC703	O
treatment	O
.	O

We	O
found	O
that	O
the	O
thermopower	O
of	O
nanowires	O
with	O
Ge	B-Chemical
core	O
diameters	O
down	O
to	O
11	O
nm	O
still	O
follows	O
the	O
behavior	O
of	O
bulk	O
Ge	B-Chemical
.	O

Furthermore	O
,	O
the	O
docking	O
study	O
demonstrated	O
that	O
paeoniflorin	B-Chemical
resided	O
in	O
the	O
LXR	O
ligand	O
-	O
binding	O
pocket	O
in	O
the	O
similar	O
manner	O
as	O
GSK	B-Chemical
3987	I-Chemical
,	O
a	O
novel	O
LXR	O
agonist	O
.	O

Thyroid	B-Chemical
hormones	I-Chemical
(	O
THs	O
)	O
play	O
a	O
pivotal	O
role	O
in	O
regulating	O
cardiovascular	O
homeostasis	O
.	O

Specifically	O
,	O
a	O
compound	O
in	O
which	O
a	O
bromine	B-Chemical
has	O
been	O
introduced	O
in	O
the	O
aromatic	O
ring	O
of	O
praziquantel	B-Chemical
demonstrated	O
close	O
antischistosomal	O
activity	O
to	O
praziquentel	B-Chemical
in	O
vivo	O
.	O

The	O
Weibull	O
mathematical	O
model	O
suggested	O
that	O
the	O
AZT	B-Chemical
is	O
released	O
by	O
Fickian	O
diffusion	O
mechanisms	O
.	O

Protective	O
action	O
of	O
ethanolic	O
extract	O
of	O
Rosmarinus	O
officinalis	O
L	O
.	O
in	O
gastric	O
ulcer	O
prevention	O
induced	O
by	O
ethanol	B-Chemical
in	O
rats	O
.	O

After	O
converting	O
to	O
Fe	B-Chemical
(	I-Chemical
III	I-Chemical
)	I-Chemical
complex	O
in	O
the	O
presence	O
of	O
Fe	B-Chemical
(	I-Chemical
III	I-Chemical
)	I-Chemical
ions	O
,	O
EDTA	B-Chemical
was	O
separated	O
on	O
a	O
reversed	O
-	O
phase	O
C30	O
column	O
and	O
detected	O
with	O
ultraviolet	O
detection	O
(	O
260	O
nm	O
)	O
.	O

Few	O
studies	O
assess	O
the	O
potential	O
of	O
ongoing	O
sources	O
of	O
"	O
fresh	O
"	O
polychlorinated	B-Chemical
biphenyls	I-Chemical
(	O
PCBs	B-Chemical
)	O
to	O
aquatic	O
systems	O
when	O
direct	O
discharge	O
to	O
the	O
environment	O
has	O
been	O
eliminated	O
.	O

2012	O
Philip	O
S	O
.	O
Portoghese	O
Medicinal	O
Chemistry	O
Lectureship	O
:	O
Structure	O
-	O
Based	O
Approaches	O
to	O
Ligands	O
for	O
G	O
Protein	O
-	O
Coupled	O
Adenosine	B-Chemical
and	O
P2Y	O
Receptors	O
,	O
From	O
Small	O
Molecules	O
to	O
Nanoconjugates	O
.	O

We	O
report	O
transparent	O
stretchable	O
single	O
-	O
walled	O
carbon	B-Chemical
nanotube	O
-	O
polymer	O
composite	O
films	O
that	O
emit	O
pronounced	O
Raman	O
and	O
near	O
-	O
infrared	O
fluorescence	O
with	O
a	O
fine	O
spatial	O
resolution	O
.	O

